Sandoz Inc Drug Patent Portfolio

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status

Sandoz Inc's Family Patents

Given below is the complete list of Sandoz Inc's drugs and the patents protecting them.

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Novo Nordisk will lose Canadian patent rights for a major medication due to the failure to pay a minor fee.

17 Jun, 2025

Three Generic Pharmaceutical Stocks to Monitor in Light of Pricing Challenges and Tariff Risks - TradingView

09 Jun, 2025

Sandoz seeks to prevent Amgen's legal team from pursuing patent claims in ongoing intellectual property dispute - Lawyerly

07 May, 2025

AstraZeneca and Merck introduce a new patent in their efforts to protect Lynparza from generic competition

21 Nov, 2024